Unaudited Condensed Interim Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Net Sales	$ 3,356,090	$ 2,312,615
Cost of Goods Sold	2,206,991	1,388,349
Gross Profit	1,149,099	924,266
Operating Expenses
Research and development	59,314	43,645
Selling. General and Administrative Expenses	3,101,226	1,601,517
Loss on impairment of goodwill	1,138,203
Total Operating Expenses	4,298,743	1,645,162
Operating Loss	(3,149,644)	(720,896)
Other Income (Expense)
Change in Fair Market Value of Warrant Liability	43,828	(311,400)
Interest expense	(4,056)
Loss on change in Fair Market Value of Contingent Consideration (Note 2)	(240,000)
Gain on Settlement of Contingent Consideration (Note 2)	1,700,000
Other Expense		(655)
Total Other Income (Expense)	1,499,772	(312,055)
Loss Before Provision for Income Taxes	(1,649,872)	(1,032,951)
Provision from Income Taxes
Net Loss	(1,649,872)	(1,032,951)
Net Loss attributable to common stockholders:
Dividends to preferred shareholders	$ (362,250)
Net Loss attributable to common stockholders
Basic and Diluted Loss Per Common Share	$ (0.16)	$ (0.12)
Weighted Average Shares Outstanding - basic and diluted	12,928,174	8,630,811